Key terms
About RPTX
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RPTX news
Mar 08
6:35am ET
Buy Rating Affirmed for Repare Therapeutics: Strong Financials and Promising Clinical Catalysts Ahead
Feb 28
4:30pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 28
4:20pm ET
SHAREHOLDER ALERT: Potential Recovery for Repare Therapeutics Inc. (RPTX) Investors
Feb 28
2:50pm ET
Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)
Feb 28
11:37am ET
Repare Therapeutics Reports Promising 2023 Progress
Feb 28
7:13am ET
Repare Therapeutics reports Q4 EPS (67c), consensus (46c)
Feb 21
6:25am ET
Strong Buy: Repare Therapeutics’ Promising Clinical Outcomes in Cancer Therapy
Feb 15
7:45am ET
Repare Therapeutics doses first patient in LIONS clinical trial
Feb 14
6:11am ET
Repare Therapeutics price target lowered to $10 from $25 at H.C. Wainwright
Feb 13
7:37am ET
Repare Therapeutics (RPTX) Gets a Buy from Stifel Nicolaus
Feb 13
7:36am ET
Piper Sandler Keeps Their Buy Rating on Repare Therapeutics (RPTX)
Feb 13
5:13am ET
Buy Rating on Repare Therapeutics: Solid Financials and Promising Oncology Pipeline Despite Roche Setback
Feb 12
5:04pm ET
Repare Therapeutics Regains Rights, Ends Roche Agreement
Feb 12
4:06pm ET
Repare Therapeutics to regain global rights to Camonsertib
Jan 26
6:20am ET
Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX) and Repare Therapeutics (RPTX)
Jan 26
4:22am ET
Repare Therapeutics Receives Milestone Payment from Roche
Jan 25
10:44am ET
Capital One says buy these six biotech stocks for 2024
Jan 25
10:44am ET
Capital One says buy these six biotech stocks for 2024
Jan 25
9:03am ET
Capital One reveals top six biotech picks for 2024
Jan 25
7:12am ET
Repare Therapeutics earns $40M milestone payment from Roche for TAPISTRY trial
Jan 09
7:38am ET
Piper Sandler Sticks to Their Buy Rating for Repare Therapeutics (RPTX)
Jan 08
7:27am ET
Repare Therapeutics pipeline with 4 clinical-stage programs by 2H24
Jan 08
7:27am ET
Repare Therapeutics pipeline with 4 clinical-stage programs by 2H24
Jan 05
7:55am ET
Repare Therapeutics (RPTX) Has a New Rating from Piper Sandler
Jan 05
6:29am ET
Repare Therapeutics’ Promising Partnerships and Pipeline Propel Buy Rating
Jan 04
4:07pm ET
Repare enters into clinical study, collaboration pact with Debiopharm
Dec 19
7:26am ET
Repare Therapeutics price target lowered to $8 from $14 at Morgan Stanley
No recent press releases are available for RPTX
RPTX Financials
Key terms
Ad Feedback
RPTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RPTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
